MetLife Inc. (MET) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    MetLife Inc.

    NYSE: MET · Real-Time Price · USD
    82.37
    1.04 (1.28%)
    At close: Oct 03, 2025, 3:59 PM
    82.50
    0.16%
    After-hours: Oct 03, 2025, 07:57 PM EDT

    MetLife Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 73.01B 73.49B 70.98B 71.35B 68.77B 67.57B 66.91B 64.19B 70.61B 69.46B 69.48B 73.25B 67.87B 71.98B 72.14B 71.47B 70.58B 65.09B
    Cost of Revenue
    		 52.6B 53.07B 50.94B 53.22B 53.58B 54.57B 56.24B 52.9B 58.55B 56.95B 55.34B 59.39B 53.41B 53.01B 54.76B 55.15B 55.34B 55.07B
    Gross Profit
    		 19.47B 19.33B 19.08B 17.45B 14.7B 12.85B 10.67B 11.3B 12.06B 12.51B 14.14B 13.86B 14.46B 18.97B 17.38B 16.32B 15.24B 10.03B
    Operating Income
    		 6.75B 6.96B 6.66B 5.96B 4.24B 3.21B 2.16B 2.95B 3.83B 4.39B 6.06B 5.64B 6.27B 9.77B 8.13B 6.98B 5.87B 1.57B
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 5.71B 5.93B 5.62B 5.18B 3.72B 2.95B 2.16B 2.95B 3.83B 4.39B 6.07B 5.64B 6.27B 9.77B 8.13B 6.98B 5.87B 1.57B
    Net Income
    		 4.29B 4.5B 4.43B 3.76B 2.91B 2.37B 1.58B 2.31B 2.99B 3.5B 5.05B 4.91B 5.33B 7.83B 6.55B 5.51B 4.63B 1.37B
    Selling & General & Admin
    		 6.11B 6.04B 5.99B 6.13B 6.19B 6.21B 6.18B 6.09B 5.99B 5.91B 5.86B 5.94B 5.91B 5.78B 5.77B 5.69B 5.67B 5.75B
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 7.54B 7.11B 7.1B 5.89B 4.55B 3.57B 2.33B 2.25B 2.24B 2.21B 2.21B 2.28B 2.28B 3.42B 3.49B 3.64B 3.7B 2.7B
    Operating Expenses
    		 13.64B 13.15B 13.09B 12.03B 10.74B 9.78B 8.5B 8.35B 8.23B 8.12B 8.07B 8.22B 8.19B 9.2B 9.26B 9.33B 9.37B 8.45B
    Interest Expense
    		 1.04B 1.03B 1.04B 1.05B 1.05B 1.05B 1.04B 1.02B 998M 968M 938M 914M 915M 917M 920M 926M 915M 919M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 66.28B 66.35B 64.15B 65.25B 64.31B 64.35B 64.74B 61.24B 66.78B 65.07B 63.41B 67.61B 61.6B 62.22B 64.02B 64.49B 64.72B 63.52B
    Income Tax Expense
    		 1.41B 1.41B 1.18B 1.4B 785M 558M 560M 614M 823M 874M 998M 712M 917M 1.92B 1.55B 1.46B 1.22B 195M
    Shares Outstanding (Basic)
    		 670.8M 682.3M 696.07M 699.3M 710.5M 723.2M 745.45M 751.4M 765.9M 769.18M 779.1M 795.8M 809.7M 830.5M 838.1M 854.9M 873.3M 878.31M
    Shares Outstanding (Diluted)
    		 675M 687M 697.9M 703.7M 714.7M 728.4M 745.46M 755.5M 769.6M 781.2M 790.2M 800.7M 814.5M 830.5M 845.2M 861.2M 879.7M 892.1M
    EPS (Basic)
    		 5.94 6.18 6.00 4.98 3.72 2.92 1.83 2.75 3.57 4.18 6.07 5.78 6.18 8.94 7.36 6.10 5.02 1.24
    EPS (Diluted)
    		 5.90 6.15 5.97 4.96 3.71 2.91 1.83 2.72 3.53 4.13 6.00 5.73 6.13 8.88 7.32 6.07 4.99 1.23
    EBITDA
    		 6.75B 6.96B 6.66B 6.23B 4.78B 4B 3.21B 3.97B 4.83B 5.36B 7B 6.56B 7.19B 10.69B 9.05B 7.91B 6.78B 2.49B
    EBIT
    		 6.75B 6.96B 6.66B 6.23B 4.78B 4B 3.21B 3.97B 4.83B 5.36B 7B 6.56B 7.19B 10.69B 9.05B 7.91B 6.78B 2.49B
    Depreciation & Amortization
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist